Antimex Chemical Limied
Assessed Supplier Enterprise Certification
- Assessed
Supplier - 9th
years
Assessed Supplier Enterprise Certification
Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Lab/Research institutions
Tel: 0086-21-50563169
Mobile:
Tel: 0086-21-50563169
Fax: 0086-21-51561690
Province/state: Shanghai
City: Shanghai
Street: Room1027,No.Jinyu Road,Pudong
MaxCard:
Contact Suppliers
Ganciclovir (ganciclovir), the chemical name 9- (1, 3-dihydroxy-2-propoxymethyl) guanine, belongs to the nucleoside antiviral drugs, being a kind of guanosine derivatives. It has broad-spectrum, high-efficient inhibitory effects on herpes virus and is the first-choice drug for the treatment of cytomegalovirus infection with strong effect on hepatitis B virus and adenovirus as well. It is homologue of acyclovir (ACV) with its antiviral effect being similar as, but stronger than aciclovir, having especially strong inhibitory effects on cytomegalovirus associated with AIDS patients.
|
1. Induction and maintenance treatment of CMV retinitis in immunocompromised patients (including AIDS patients). 2. Prevention of cytomegalovirus infection in patients receiving organ transplants and prophylaxis of cytomegalovirus disease in HIV-positive patients with cytomegalovirus seroprevalence. For immunodeficient patients with life-threatening or vision-related cytomegalovirus (CMV) infections, such as AIDS, exogenous immunosuppressive patients associated with organ transplantation and tumor chemotherapy. Antiviral drugs, for the treatment of cytomegalovirus (CMV) infections caused by low immune capability. For antiviral drugs intermediates |
|
1. Induction and maintenance treatment of CMV retinitis in immunocompromised patients (including AIDS patients). 2. Prevention of cytomegalovirus infection in patients receiving organ transplants and prophylaxis of cytomegalovirus disease in HIV-positive patients with cytomegalovirus seroprevalence. For immunodeficient patients with life-threatening or vision-related cytomegalovirus (CMV) infections, such as AIDS, exogenous immunosuppressive patients associated with organ transplantation and tumor chemotherapy. Antiviral drugs, for the treatment of cytomegalovirus (CMV) infections caused by low immune capability. For antiviral drugs intermediates |